Galderma Announces Publication of Pivotal Phase 3 PERFECT 1 and PERFECT 2 Clinical Trials of Trifarotene in Patients with Moderate Facial and Truncal Acne in the Journal of the American Academy of Dermatology
Advertisement
Both Studies of Next-Generation Topical Retinoid for Acne on the Face, Chest and Back Met All Primary and Secondary Efficacy Endpoints